Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Osteosarcoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all

Phase

Phase 3 1 Phase 2/3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 6 Carcinoma, Non-Small-Cell Lung 5 Medulloblastoma 4 Lung Neoplasms 4 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Oropharyngeal Neoplasms 2 Neuroblastoma 2 Carcinoma, Transitional Cell 2 Vaginal Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Tongue Neoplasms 1 Teratoma 1 Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1 Salivary Gland Neoplasms 1 Rhabdoid Tumor 1 Recurrent Uterine Corpus Carcinoma 1 Prostatic Neoplasms 1 PRETEXT I Hepatoblastoma 1 Osteosarcoma 1 Neoplasms, Germ Cell and Embryonal 1 Nasopharyngeal Carcinoma 1 Mouth Neoplasms 1 Mesothelioma, Malignant 1 Mesothelioma 1 Lymphoid Interstitial Pneumonia 1 Locally Advanced Cervical Adenocarcinoma 1 Laryngeal Neoplasms 1 Hypopharyngeal Neoplasms 1

Interventions

Methotrexate 4 Doxorubicin 3 Ifosfamide 2 Etoposide 2 Cisplatin 2 peginterferon alfa-2b 1 merphos 1 Zoledronic Acid 1 Triptorelin Pamoate 1 Thoracotomy 1 Thoracostomy 1 Thoracoscopy 1 Specimen Handling 1 Platinum 1 IMVP-16 protocol 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Fentanyl 1 Cyproheptadine 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00134030 2023-06-07

EURAMOS-1

Children's Oncology Group

Phase 3 Completed

1,334 enrolled 17 charts

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡